DYEE Capital
Xiamen, Fujiandyeecapital.com
Overview
DYEE Capital, founded in June 2016, is an early and growth stage venture capital firm based in Xiamen, China . The firm has also invested in private equity opportunities and seeks to make investments in sectors such as information services, consumption, medical, and healthcare .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jiangsu Vcare Pharmatech Co., Ltd. | Jan 2024 | Series C | Lead |
| Shanghai Yingli Pharmaceutical Co., Ltd. | Nov 2023 | Series A Extension | Co-investor |
| Genepoint Biological Technology | Jan 2023 | Series D | Co-investor |
| BridGene Biosciences | Jul 2022 | Series B | Co-investor |
| Degron Therapeutics | Jun 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
